<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03978819</url>
  </required_header>
  <id_info>
    <org_study_id>DC 2015/143</org_study_id>
    <nct_id>NCT03978819</nct_id>
  </id_info>
  <brief_title>ANI Parasympathetic Monitoring in Neurosurgery</brief_title>
  <acronym>ANI</acronym>
  <official_title>Ability of the Analgesia Nociception Index Monitor to Distinguish Between Excessive Analgesia and Inadvertent Parasympathetic Nerve Stimulation During Surgery of Large Cerebellopontine Angle Tumours</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association de Developpement de la Neuroanesthesie Reanimation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Association de Developpement de la Neuroanesthesie Reanimation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgery of large cerebellopontine angle (CPA) tumors (&gt;2 x 2 cm diameter), with compression
      of the pons exposes the patient to inadvertent parasympathetic nerve stimulation (IPNS)
      leading to bradycardia and asystole.

      The analgesia nociception index (ANI) monitor assesses the balance between analgesia and
      nociception through the detection of parasympathetic tone. ANI &gt;80 generally denotes
      excessive analgesia (EA). The main objective of this study was to determine whether ANI
      values for IPNS are different or the same as ANI values for EA. This study also aims at
      calculating the number of patients with IPNS and EA during surgery of large CPA tumours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bradycardia and asystole are potential life threatning complications during surgery of large
      cerebellopontine angle (CPA) tumors (&gt;2 x 2 cm diameter), with compression of the pons.The
      incidence of such complications are unknown. One of the plausible mechanisms is inadvertent
      parasympathetic nerve stimulation (IPNS) due to the proximity of this cranial nerve to the
      CPA tumor. Monitoring parasympathetic nerve activity may provide further insight to the
      implication of this cranial nerve in the cardiac complications observed during surgery of
      large CPA tumors. The analgesia nociception index (ANI) monitor assesses the balance between
      analgesia and nociception through the detection of parasympathetic tone. Despite the abundant
      clinical reports about this index, to the knowledge of the investigators, only a few studies
      have been published in the neurological setting. Moreover, there are no data reporting the
      parasympathetic profile (measured by the ANI monitor) in situations of IPNS and EA. Are these
      profiles the same or different? Such is the main question this study thrives to answer.
      Understanding the behavior of parasympathetic nerve activity in this context could help
      provide the appropriate management strategy.

      In order to answer this question, participants undergoing elective large CPA tumor surgery
      were included in this prospective observational study. Standard cardiorespiratory monitoring
      including heart rate (HR) was done. Target-controlled anesthesia with Propofol and
      Remifentanil was guided by a bispectral index of 30-40 and an ANI of 50-70 respectively. Data
      was continuously recorded with event markers at the onset of bradycardia (HR &lt; 45 bpm),
      asystole and the coincidence of ANI &gt; 80 with Remifentanil site effect &gt; 6 ng.ml-1 (defined
      as excessive analgesia).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in instantaneous ANI (ANIi) values during bradycardia versus ANIi values when Remifentanil effect size concentration &gt;6ng/mL</measure>
    <time_frame>ANIi values recorded at Day 1 only during surgery (duration: 4-6 hours)</time_frame>
    <description>ANI, HR and Remifentanil effect site concentration were continuously recorded with event markers on the ANI monitor at the onset of bradycardia (HR&lt;45 bpm) or Remifentanil effect site concentration&gt;6ng/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Differences in the area under the ROC curves between ANI values for IPNS and EA analgesia</measure>
    <time_frame>ANIi values recorded at Day 1 only during surgery (duration: 4-6 hours)</time_frame>
    <description>ROC curves were built at different ANIi for IPNS or EA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentages of IPNS and EA cases</measure>
    <time_frame>Cases observed at Day 1 only during surgery (duration: 4-6 hours)</time_frame>
    <description>The percentages of IPNS or EA cases on the overall study population were calculated.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Bradycardia</condition>
  <arm_group>
    <arm_group_label>Patients with large CPA tumors</arm_group_label>
    <description>Patients with large cerebellopontine angle tumors (&gt;2 x 2cm) undergoing elective surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ANI</intervention_name>
    <description>ANI profiles during IPNS (bradycardia/asystole) or excessive analgesia.
During surgery continuous monitoring of ANI, HR and Remifentanil effect site concentration was done and recorded. Event markers were placed at the onset of bradycardia, asystole and the coincidence of ANI&gt;80 + Remifentanil &gt;6ng/mL). ANI values of 1 min before and 1 min after the event were used for analysis.</description>
    <arm_group_label>Patients with large CPA tumors</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female with large cerebellopontine angle tumors (&gt;2 x 2 cm)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing elective surgery of large cerebellopontine angle tumors

        Exclusion Criteria:

          -  age below 18yr

          -  arrhythmia

          -  preoperative use of vagolytics, β-blockers and clonidine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Musa Sesay, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>ADNR, Neuroanesthesia and Critical Care, 33076 Bordeaux, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthieu Biais, M.D., PhD</last_name>
    <role>Study Director</role>
    <affiliation>Neuroanesthesia and Critical Care, CHU University Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karine Nouette-Gaulain, M.D., Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Neuroanesthesia and Critical Care, CHU University Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Bordeaux University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Renowden S. Imaging of the cerebello-pontine angle. Pract Neurol. 2014 Oct;14(5):e2. doi: 10.1136/practneurol-2014-000949. Epub 2014 Aug 12. Review.</citation>
    <PMID>25118279</PMID>
  </reference>
  <reference>
    <citation>Sesay M, Vignes JR, Stöckle M, Mehsen M, Boulard G, Maurette P. [Spectral analysis of the ECG R-R interval permits early detection of vagal responses to neurosurgical stimuli]. Ann Fr Anesth Reanim. 2003 May;22(5):421-4. French.</citation>
    <PMID>12831969</PMID>
  </reference>
  <reference>
    <citation>De Jonckheere J, Rommel D, Nandrino JL, Jeanne M, Logier R. Heart rate variability analysis as an index of emotion regulation processes: interest of the Analgesia Nociception Index (ANI). Conf Proc IEEE Eng Med Biol Soc. 2012;2012:3432-5. doi: 10.1109/EMBC.2012.6346703.</citation>
    <PMID>23366664</PMID>
  </reference>
  <reference>
    <citation>Jeanne M, Clément C, De Jonckheere J, Logier R, Tavernier B. Variations of the analgesia nociception index during general anaesthesia for laparoscopic abdominal surgery. J Clin Monit Comput. 2012 Aug;26(4):289-94. doi: 10.1007/s10877-012-9354-0. Epub 2012 Mar 28.</citation>
    <PMID>22454275</PMID>
  </reference>
  <reference>
    <citation>Robin F, Sesay M, Kolanek B, Pena D, Penna M, Morel-Locket L et al. The analgesia nociception index monitor (ANI) can detect indvertent vagal stimulation during surgery of cerebello-pontine angle tumors. Br J Anaesth 2013;111: https: // doi.org/10.1093/bja/el_10195</citation>
  </reference>
  <reference>
    <citation>Kommula LK, Bansal S, Umamaheswara Rao GS. Analgesia Nociception Index Monitoring During Supratentorial Craniotomy. J Neurosurg Anesthesiol. 2019 Jan;31(1):57-61. doi: 10.1097/ANA.0000000000000464.</citation>
    <PMID>28991059</PMID>
  </reference>
  <reference>
    <citation>Theerth KA, Sriganesh K, Reddy KM, Chakrabarti D, Umamaheswara Rao GS. Analgesia Nociception Index-guided intraoperative fentanyl consumption and postoperative analgesia in patients receiving scalp block versus incision-site infiltration for craniotomy. Minerva Anestesiol. 2018 Dec;84(12):1361-1368. doi: 10.23736/S0375-9393.18.12837-9. Epub 2018 Jul 9.</citation>
    <PMID>29991223</PMID>
  </reference>
  <reference>
    <citation>Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth. 2014 Jun;112(6):991-1004. doi: 10.1093/bja/aeu137. Review.</citation>
    <PMID>24829420</PMID>
  </reference>
  <reference>
    <citation>Galley HF. Editorial II: Solid as a ROC. Br J Anaesth. 2004 Nov;93(5):623-6.</citation>
    <PMID>15472141</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 21, 2019</study_first_submitted>
  <study_first_submitted_qc>June 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>June 5, 2019</last_update_submitted>
  <last_update_submitted_qc>June 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Association de Developpement de la Neuroanesthesie Reanimation</investigator_affiliation>
    <investigator_full_name>Musa Sesay</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Analgesia nociception index</keyword>
  <keyword>Parasympathetic nerve stimulation</keyword>
  <keyword>Excessive analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 5, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT03978819/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

